Effect of TIEG1 on apoptosis and expression of Bcl-2/Bax and Pten in leukemic cell lines

Genetics and Molecular Research

Volumn 14, Issue 1, 2015, Pages 1968-1974

  Yao, K ^a   Xing, H C ^b   Wu, B ^a   Li, Y ^a   Liao, A J ^a   Yang, W ^a   Liu, Z G ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Bcl 2 Bax; Leukemic cells; Pten; TIEG1

Indexed keywords

APOPTOSIS INDUCING FACTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA INDUCIBLE EARLY GENE 1; UNCLASSIFIED DRUG; BAX PROTEIN, HUMAN; EARLY GROWTH RESPONSE FACTOR; KLF10 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; PTEN PROTEIN, HUMAN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION; HL 60 CELL LINE; IC50; INCUBATION TIME; K562 CELL LINE; LEUKEMIA CELL LINE; MINIMUM INHIBITORY CONCENTRATION; MTT ASSAY; PROTEIN EXPRESSION; RAJI CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; U937 CELL LINE; CELL PROLIFERATION; GENETICS; HUMAN; METABOLISM;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL PROLIFERATION; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; HL-60 CELLS; HUMANS; K562 CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; U937 CELLS;

EID: 84925324901     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.March.20.6     Document Type: Article

References (20)

1. Brooks C and Dong Z (2007). Regulation of mitochondrial morphological dynamics during apoptosis by Bcl-2 family proteins: a key in Bak. Cell Cycle 6: 3043-3047.
2. Cory S and Adams JM (2002). The Bcl-2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2: 647-656.
3. Dahia PL, Aguiar RC, Alberta J, Kum JB, et al. (1999). PTEN is inversely correlated with the cell survival factor Akt/ PKB and is in activated via multiple mechanisms in haematological malignancies. Hum. Mol. Genet. 8: 185-193.
4. Dosen-Dahl G, Munthe E, Nygren MK, Stubberud H, et al. (2008). Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFbeta/BMP-6 and TIEG1 in chemotherapy escape. Int. J. Cancer 123: 2759-2766.
5. Duenker N, Valenciano AI, Franke A, Hernández-Sánchez C, et al. (2005). Balance of pro-apoptotic transforming growth factor-beta and anti-apoptotic insulin effects in the control of cell death in the postnatal mouse retina. Eur. J. Neurosci. 22: 28-38.
6. Hefferan TE, Reinholz GG, Rickard DJ, Johnsen SA, et al. (2000). Overexpression of a nuclear protein, TIEG, mimics transforming growth factor-beta action in human osteoblast cells. J. Biol. Chem. 275: 20255-20259.
7. Jiang L, Wang F, Lin F, Gao SM, et al. (2011). Lentivirus-mediated overexpression of TGF-b inducible early gene 1 inhibits SW1990 pancreatic cancer cell growth. Cell Biol. Int. 35: 891-896
8. Jiang L, Lai YK, Zhang JF, Chan CY, et al. (2012). Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-b-susceptible hepatocellular carcinoma cells. World J. Gastroenterol. 18: 2035-2042.
9. Jin W, Qu LF, Min P, Chen S, et al. (2004). Identification of genes responsive to apoptosis in HL-60 cells. Acta Pharmacol. Sin. 25: 319-326.
10. Jin W, Chen BB, Li JY, Zhu H, et al. (2012). TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway. Mol. Cell. Biol. 32: 50-63.
11. Mathai JP, Germain M and Shore GC (2005). BH3-only BIK regulates BAX, BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J. Biol. Chem. 280: 23829-23836.
12. Myers MP, Stolarov JP, Eng C, Li J, et al. (1997). P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. U S A 94: 9052-9057.
13. Reinholz MM, An MW, Johnsen SA, Subramaniam M, et al. (2004). Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer. Res. Treat. 86: 75-88.
14. Song KD, Kim DJ, Lee JE, Yun CH, et al. (2012). KLF10, transforming growth factor-b-inducible early gene 1, acts as a tumor suppressor. Biochem. Biophys. Res. Commun. 419: 388-394.
15. Subramaniam M, Hefferan TE, Tau K, Peus D, et al. (1998). Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene. J. Biol. Chem. 68: 226-236.
16. Tamura M, Gu J, Matsumoto K, Aota S, et al. (1998). Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614-1617.
17. Wu B, Wang X, Chi ZF, Hu R, et al. (2012). Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway. Arch. Pharm. Res. 35: 543-548.
18. Xu Q, Simpson SE, Scialla TJ, Bagg A, et al. (2003). Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 102: 972-980.
19. Yang J, Liu J, Zheng J, Du W, et al. (2007). A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia. Leukemia 21: 2072-2074.
20. Yilmaz OH, Valdez R, Theisen BK, Guo W, et al. (2006). Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441: 475-482.